Drugging the Undruggable - Clinical Oncology News
<img alt="" height="1" width="1" /> Drugging the Undruggable Clinical Oncology News In his talk at NCRI, Dr. Fang discussed Genentech's preliminary success determining the druggability of Ras using nuclear magnetic resonance (NMR)-based fragment screening. â??We analyzed the binding of molecules to the Ras protein itself, not yet asking ... Drugging the Undruggable - Clinical Oncology News More... |
All times are GMT. The time now is 09:17 AM. |
Powered by vBulletin® Version 3.7.3
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Search Engine Friendly URLs by vBSEO 3.6.0
Copyright, BioNMR.com, 2003-2013